00000nam 2200000zi 4500 9.944716 CaOODSP 20250220111547 m o d f cr |n||||||||| 241031t20242024oncd ob f000 0 eng d 9780660742755 CaOODSP eng rda CaOODSP n-cn--- HP40-355/1-1-2024E-PDF Statement on the prevention of respiratory syncytial virus (RSV) disease in infants. Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, 2024. ©2024 1 online resource (67 pages) : graph text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Déclaration sur la prévention de la maladie causée par le virus respiratoire syncytial (VRS) chez les nourrissons. At head of title: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI). "Revised publication: 2024." "Pub.: 240619." Includes bibliographical references (pages 56-67). Respiratory syncytial virus Vaccination Government policy Canada. Viral vaccines Government policy Canada. Vaccination of infants Government policy Canada. Vaccination of children Government policy Canada. Public Health Agency of Canada, issuing body. Déclaration sur la prévention de la maladie causée par le virus respiratoire syncytial (VRS) chez les nourrissons. (CaOODSP)9.944717 Statement on the prevention of respiratory syncytial virus (RSV) disease in infants. (CaOODSP)9.935753 PDF 921 KB https://publications.gc.ca/collections/collection_2025/aspc-phac/HP40-355-1-1-2024-eng.pdf HTML N/A https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-statement-prevention-respiratory-syncytial-virus-disease-infants.html